Immunodiagnostic Systems Holdings plc provides earnings guidance for the six months ended 30 September 2013. Total revenues are expected to be £27 million representing 13% growth in revenues compared to the prior year equivalent period. The increase in revenue was driven by the continued growth in automated revenues of 37%, compared to the prior year period.
Immunodiagnostic Systems Holdings PLC
Equities
IDH
GB00B01YZ052
Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | |
---|---|---|
-5.72% | 12.09B | |
-3.26% | 8.21B | |
+5.15% | 5.74B | |
+31.20% | 5.64B | |
-9.05% | 4.16B | |
-56.99% | 2.88B | |
+11.87% | 2.69B | |
-5.65% | 2.33B | |
+25.34% | 2.17B |